Preprint
Article

This version is not peer-reviewed.

From Chemical Composition to Biological Activity: Phytochemical, Antioxidant, and Antimicrobial Comparison of Matricaria chamomilla and Tripleurospermum inodorum

A peer-reviewed article of this preprint also exists.

Submitted:

07 October 2025

Posted:

08 October 2025

You are already at the latest version

Abstract
Matricaria chamomilla and Tripleurospermum inodorum are closely related Asteraceae plants that share morphology but differ in chemistry and bioactivity. This study investigated both species using an integrative approach combining microscopy, phytochemical profiling, and biological evaluations. Phenolic and flavonoid contents were quantified spectropho-tometrically, and essential oils analyzed by hydrodistillation–GC–MS. Antioxidant activity was determined using the DPPH assay, and antimicrobial effects assessed. Microscopy confirmed diagnostic differences. M. chamomilla contained more polyphenols (20.48 vs. 17.88 mg GAE/g DW), whereas T. inodorum showed higher flavonoid levels (15.93 vs. 13.87 mg RE/g DW). Their oils exhibited distinct chemotypes: in M. chamomilla, oxygenated ses-quiterpenes predominated (76.8%), mainly bisabolol oxide A (39.5%), bisabolol oxide B (18.7%), bisabolone oxide A (12.7%), β-farnesene (8.0%), trans-lachnophyllum ester (6.2%), and chamazulene (4.2%); in T. inodorum, the oil was dominated by β-farnesene (11.6%) and cis-lachnophyllum ester (11.6%), with a late signal tentatively assigned to 1,3-naphthalenediol. Antioxidant activity was moderate (IC₅₀ 17.7–21.5 µg/mL for M. chamomilla; 8.4–10.2 µg/mL for T. inodorum). Antimicrobial tests showed T. inodorum active against S. aureus and C. albicans, while M. chamomilla was effective only against C. albicans. These results underline chemical markers differentiating the taxa and support T. inodorum as a complementary source of bioactive compounds.
Keywords: 
;  ;  ;  ;  ;  ;  

1. Introduction

Matricaria chamomilla L., sin. Chamomilla recutita (L.) Rauschert (German chamomile) is an annual species widely cultivated across Europe, Asia, and the Americas. It thrives in well-drained, moderately fertile soil, and is commonly found in cultivated fields and gardens, but also in wild areas [1]. In contrast, Tripleurospermum inodorum (syn. Matricaria inodora), commonly known as scentless mayweed, or scentless chamomile, is a ruderal species that grows spontaneously in uncultivated lands, field margins, and roadsides. It is often considered an invasive weed, being highly adaptable to diverse environmental conditions [2].
Although both species belong to Asteraceae family and display capitulate inflorescences, they exhibit significant morphological differences. Matricaria chamomilla (M. chamomilla) has erect stems, pinnatisect leaves, and a hollow, conical receptacle, bearing white ligulate florets and yellow tubular disc florets [1,3]. In contrast, Matricaria inodora sin. Tripleurospermum inodorum (T. inodorum) features more finely divided, feathery leaves and a solid receptacle. Its inflorescences are similar in appearance but lack the characteristic aroma of true chamomile, which is a key trait for accurate identification [2].
The chemical composition of M. chamomilla has been extensively studied and is characterized by a rich and complex profile of secondary metabolites. The essential oil of chamomile typically contains α-bisabolol, chamazulene, matricin, bisabolol oxides A and B, β-farnesene, and spathulenol [3]. These constituents vary depending on the plant’s origin, geographical position, harvesting time, and extraction method. Based on the main component of the essential oils, there are few chemotypes of chamomile: type A (bisabolol oxide A predominant), type B (bisabolol oxide B predominant), type C (alpha-bisabolol predominant), and type D (α-bisabolol, and α-bisabolol oxide A and B in 1:1 ratio) [4,5].
Among the flavonoids found in large amounts in chamomile, apigenin, apigenin-7-O-glucoside, luteolin, patuletin, and quercetin are included. Other notable biocomponds are phenolic acids (caffeic acid, chlorogenic acid, and ferulic acid), coumarins (herniarin, umbelliferone), mucilages, polysaccharides, small amounts of tannins and bitter substances (matricarin) [6,7]. These constituents contribute to its numerous pharmacological effects.
Preparations from M. chamomilla are traditionally used for their anti-inflammatory, antispasmodic, sedative, carminative, and antiseptic properties. Chamomile is administered as teas, infusions, tinctures, or essential oils for gastrointestinal disorders, anxiety, skin irritations, and mucosal inflammation [3]. Recent clinical studies have highlighted the therapeutic potential of M. chamomilla in anxiety, insomnia, and inflammation-related conditions. A double-blind, placebo-controlled trial showed that chamomile extract significantly reduced anxiety symptoms in patients with generalized anxiety disorder [8]. A follow-up study confirmed its role in preventing relapses and improving long-term well-being [9]. Additionally, a meta-analysis found that chamomile improved sleep quality and reduced night-time awakenings [10]. Topical chamomile oil has also shown benefits in reducing pain and inflammation in patients with carpal tunnel syndrome [11]. M. chamomilla is generally considered safe, with low toxicity, although allergic reactions may occur in individuals sensitive to Asteraceae species. Potential interactions with anticoagulants have also been noted [12].
T. inodorum is less chemically and pharmacologically studied species. So far it is known that it contains a significantly lower amount of essential oil, typically below 0.05%, and the composition varies. Unlike M. chamomilla, it lacks chamazulene and α-bisabolol. Identified constituents include α-pinene, limonene, β-myrcene [13,14], artemisia ketone, terpinene-4-ol, 1,8-cineole, sabinene, tricosane [2], and matricaria ester [15]. Other components are flavonoids (apigenin, luteolin, quercetin, kaempferol, and isorhamnetin derivatives), phenolic acids (caffeic acid, p-coumaric acid, quinic acid, 5-O-caffeoyl quinic acid, and protocatechuic acid), tannins and terpenoids, and smaller doses of sesquiterpene lactones than chamomile [2,7]. Nonetheless, its phytochemical profile remains less characterized and more variable. T. inodorum is rarely cited in traditional medicine. Few studies have reported antioxidant activity [14,15], alleviating gastrointestinal pain and anti-inflammatory properties [16], but its therapeutic relevance remains uncertain due to low concentrations of active constituents. Regarding T. inodorum, there is limited data on toxicity, but it is typically regarded as non-toxic, with low allergenic potential.
The aim of this study was to provide a comparative evaluation of the bioactive compounds of two chamomile species: M. chamomilla and T. inodorum, including total polyphenols, flavonoids, and volatile constituents from the essential oils, analyzed by GC-MS, and to explore how these bioactive compounds contribute to antioxidant and antimicrobial activities.

2. Materials and Methods

Flowers at full maturity or floral buds from the two chamomile species were collected in May 2025 in the village of Dumitresti, Vrancea County, Romania. The studied species included Matricaria chamomilla L. (chamomile, German chamomile, blue chamomile), and Matricaria inodora L. sin. Tripleurospermum inodorum (L.) Sch.Bip. (scentlesss mayweed, scentless chamomile). Species identification was performed at the Botany Laboratory of the Faculty of Pharmacy, Titu Maiorescu University.
For the total phenolic and flavonoid content, and for the determination of antioxidant capacity, the plant material was air-dried at room temperature in the absence of direct light, then finely ground. Ethanolic extracts were obtained by refluxing 1 gram of the dried material with 100 mL of 50% ethanol for 30 minutes at 100 °C using an electric water bath (Witeg Labortechnik, Wertheim, Germany). The resulting mixtures were filtered through a Whatman ashless filter paper, and the final volumes were adjusted to 100 mL with the same solvent in a graduated flask. The two extracts were stored at 4 °C until the analyses were performed.

2.1. Botanical Examination

For morphological observation representative capitula of both species were selected and dissected. Floral parts—including ray and disc florets, receptacle structure—were examined and photographed using a Motic BA310 optical microscope equipped with an integrated Motic digital imaging system (Motic Microscopes, Kowloon, Hong Kong). Observations were conducted under brightfield illumination at magnifications ranging from ×10 to ×100. Morphological characteristics such as floret arrangement, symmetry, corolla type, and receptacle shape were recorded for each species. Comparative measurements of floral structures were taken, and taxonomic identification was confirmed with standard floristic keys and herbarium references.
For pollen analysis of the plants, mature anthers from fully developed disc florets were carefully removed and mounted on glass slides. Samples were analyzed under the same optical microscope Motic BA310 at ×100 magnification (Motic Microscopes, Kowloon, Hong Kong). Parameters such as pollen shape, size (polar and equatorial diameter), aperture number and type (colpi and pori), and exine ornamentation were analyzed. Measurements were performed on at least 10 pollen grains per species. Pollen grains were described following Erdtman’s system, and the terminology following standard palynological nomenclature [17,18].

2.2. Phytochemical Investigations

2.2.1. Total Phenolic Content

The total polyphenolic content of the two species was determined using a spectrophotometric method based on the Folin–Ciocalteu reagent, with gallic acid employed as calibration standards, as previously described [19,20].
Briefly, 1 mL of each hydroethanolic extract (M. chamomilla and T. inodorum flowers) was mixed with 4.5 mL of deionized water and 2.5 mL of a diluted Folin–Ciocalteu reagent (Sigma Chemical Co., St. Louis, MO, USA). After 5 minutes, 2 mL of 7% (w/v) sodium carbonate solution was added to the mixture. The reaction mixtures were incubated for 30 minutes at room temperature, protected from light. Absorbance was measured at 765 nm using a VWR UV-6300 PC spectrophotometer (VWR International, Wien, Austria).
The total polyphenolic content was quantified using calibration curves constructed with standard solutions of gallic acid (Sigma Chemical, St. Louis, MI, USA), with R² = 0.999728 and the following regression equation:
C o n c e n t r a t i o n = 77.5789 x A b s o r b a n c e
Results were expressed as milligrams of gallic acid equivalents per gram of dry weight (mg GAE/g DW). All measurements were conducted in triplicate, and data were reported as mean ± standard deviation.

2.2.2. Total Flavonoid Content

For the determination of total flavonoid content, the spectrophotometric method with aluminum chloride in the presence of sodium acetate was used, as described in the 10th edition of the Romanian Pharmacopoeia, where the absorbance of the yellow complex formed allows quantification of total flavonoids [21].
10 mL of ethanolic extracts of the two species were diluted with methanol in 25 mL volumetric flasks and filtered. To 5 mL of the diluted extract solutions, 5 mL of 100 g/L sodium acetate solution (Sigma Chemical, St. Louis, MI, USA), and 3 mL of 25 g/L aluminum chloride solution (Merck Group, Darmstadt, Germany) were added, then topped up with methanol in 25 mL volumetric flasks and the mixture was homogenized. The samples were incubated for 15 minutes at room temperature and absorbance was measured at 430 nm using a VWR UV-6300 PC spectrophotometer (VWR International, Wien, Austria), using a calibration curve made with rutin (Sigma Chemical, St. Louis, MI, USA).
The results were expressed as mg rutin equivalent per gram dry weight (mg RE/g DW) ± standard deviation, as the measurements were carried out in triplicate.

2.2.3. Essential Oil Extraction and GC/MS Analysis

Freshly ground chamomile and scentless mayweed (150 g) were subjected to hydrodistillation in a closed-loop system using a glass Clevenger-type apparatus for 3 hours. The extraction was performed with 600 mL of distilled water, following the volumetric assay method described in the 10th edition of the European Pharmacopoeia [22]. This procedure was conducted in triplicate for each species to ensure consistency of results.
The essential oil yield was calculated as a percentage (% v/w), based on the volume of oil obtained relative to the mass of plant material.
Subsequently, the chemical composition of each essential oil was determined using Gas Chromatography–Mass Spectrometry (GC–MS). The analysis was performed using a Thermo Electron Corporation Focus gas chromatograph equipped with a splitter and coupled to a Thermo Electron Corporation DSQII mass spectrometer (Thermo Scientific, Waltham, MA, USA). The capillary column was coated with Macrogol 20,000 (Ohio Valey, OH, USA), with a film thickness of 0.25 µm, a length of 30 m, and an internal diameter of 0.25 mm. Helium was used as the carrier gas at a flow rate of 1.5 mL/min. The injection volume was 1.0 µL, and the column oven temperature was programmed to increase from 65 °C to 200 °C, over a 60-minute run time [23]. Quantification of components was based on integration of peak areas in the chromatograms, and compound identification was achieved by comparing the obtained mass spectra with reference spectra from the Wiley 8 and NIST 07 databases.

2.3. Biological Activity Assays

2.3.1. Antioxidant Capacity

The antioxidant activity of the two flowers extracts was evaluated using the DPPH (2,2-diphenyl-1-picrylhydrazyl) radical scavenging assay. This widely used method is based on the reduction of the stable, violet-colored DPPH radical by antioxidants capable of donating electrons or hydrogen atoms, resulting in a color change from deep purple to pale yellow as the radical is neutralized [20].
For the preparation of the DPPH solution, 100 mg of DPPH (Sigma Chemical, St. Louis, MI, USA) was dissolved in methanol and brought to volume in a 200 mL volumetric flask. 1 mL of extract was combined with 5 mL of the DPPH solution and methanol was added to reach a final volume of 25 mL. The mixture was thoroughly homogenized and incubated for 30 minutes at room temperature in the dark to prevent photo-degradation of the radical.
After incubation, the absorbance of the solution was measured at 517 nm using a VWR UV-6300 PC spectrophotometer (VWR International, Wien, Austria). The radical scavenging activity was calculated using the following equation:
D P P H   s c a v e n g i n g   a c t i v i t y ( % ) = A b s   c o n t r o l A b s   s a m p l e A b s _ c o n t r o l
where Abs control represents the absorbance of the DPPH solution without extract, and Abs sample represents the absorbance of the DPPH solution containing the sample.
The IC₅₀ value, indicating the concentration needed to inhibit DPPH radical activity by half, was used to express the antioxidant capacity of the samples.

2.3.2. Antimicrobial Activity

Antimicrobial activity was evaluated against reference strains: Staphylococcus aureus (ATCC 25923, Escherichia coli ATCC 35218), Pseudomonas aeruginosa (ATCC 27853), and Candida albicans (ATCC 10231). Bacteria were cultured on Plate Count Agar at 37 °C for 22 ± 2 h. The antimicrobial effect of the oils was assessed by the Kirby–Bauer diffusion method under standardized, reproducible conditions [24,25].
Mueller–Hinton agar plates were inoculated with a 0.5 McFarland suspension (OD550 = 0.125) of each strain, and essential oils were applied in spots of 5–30 µL. After pre-diffusion (15 min), plates were incubated at 35 ± 2 °C for 16–18 h under aerobic conditions. Any inhibition zone was recorded as sensitivity (S), while its absence indicated resistance (R).

2.4. Statistical Data Processing

Statistical analyses were performed using XL STAT software. The results are expressed as mean ± standard deviation (SD), and differences were evaluated using analysis of variance (ANOVA). All experiments were conducted in triplicate

3. Results

3.1. Botanical Examination

The morphological examination indicates that both species exhibit capitulum-type inflorescences, specific to Asteraceae family, but with distinct differences. In M. chamomilla, the receptacle was conical and hollow, while in T. inodorum the receptacle appeared flat and solid. This is a key taxonomic feature, that enables an accurate differentiation between the two species (Figure 1). Moreover, ray florets in M. chamomilla were ligulate, strap-shaped, having three teeth at apex, and white, while in T. inodorum the ray florets were also white, strap-shaped, but more deeply three-lobed. The disc florets in M. chamomilla were tubular, bright yellow colored, with prominent bifid stigmas, while in T. inodorum they were golden-yellow, more compact, having a reduced stigma structure. Additional images of botanical examination are presented in Supplementary Figure S1.
Pollen of M. chamomilla appeared spheroidal, isopolar, and tricolporate, with a diameter of approximately 22–27 µm. The exine surface was finely reticulate, and the colpi were well defined, extending nearly the entire length of the grain. In contrast, pollen of T. inodorum was similarly spheroidal, and tricolporate, but slightly larger, with a diameter of 25–30 µm. The exine ornamentation was coarser, and the colpi appeared smoother, and less defined compared to M. chamomilla. Minor variations in aperture size and exine thickness were also observed. These palynological features also contribute to a more precise distinction between the two chamomile species, being used as supportive criteria for their identification. Additional data is provided in Figure S2 (Supplementary Material).
Botanical differences of the two species are presented in Table 1.

3.2. Total Phenolic Content

Total polyphenol content of M. chamomilla and T. inodorum was determined using gallic acid (mg GAE) and caffeic acid (mg CAE) as reference standards. The results are expressed as equivalents per gram of dry weight (DW), as shown in Table 2.
Analysis of the results indicates that M. chamomilla has the highest total polyphenol content, both in gallic acid equivalents (20.48 mg/g) and caffeic acid equivalents (20.10 mg/g). In comparison, T. inodorum showed lower values—17.88 mg/g (gallic acid) and 17.73 mg/g (caffeic acid), respectively. These differences in polyphenol content may be correlated with phytochemical composition variations between the two species, suggesting a higher antioxidant potential for chamomile flowers.

3.3. Total Flavonoid Content

The total flavone content of M. chamomilla and T. inodorum was determined and expressed as g% rutin equivalents, and the results are expressed relative to dry weight (DW), as shown in Table 3.
The results showed values of 13.872 ± 0.009 mg/g for M. chamomilla and 15.925 ± 0.005 mg/g for T. inodorum. The flowers of T. inodorum contain slightly more flavonoids than those of M. chamomilla, which may contribute to a greater overall antioxidant capacity. Although M. chamomilla is traditionally regarded as the plant with stronger medicinal properties, the present results indicate that T. inodorum may also represent a valuable source of bioactive compounds, particularly flavonoids.

3.4. Hydrodistillation and GC/MS Analysis

Through hydrodistillation of two types of chamomile flowers, distinct essential oils were obtained.
The oil from M. chamomilla was characterized as a deep blue liquid, a feature attributed to the presence of chamazulene formed during the distillation process. Its aroma was strong, sweet, herbaceous, and slightly fruity. The essential oil content was 0.75 ± 0.008 mL per 100 g of plant material.
In contrast, the oil from T. inodorum appeared as a yellow liquid with considerably lower viscosity and a weakly herbaceous to camphoraceous odor. The essential oil content was 1.14 ± 0.007 mL per 100 g of plant material.
The major compounds revealed by GC-MS analysis of the M. chamomilla essential oil are presented in Table 4 and Table 5. The detailed GC-MS chromatograms of the two essential oils are presented in Figures S3 and S4 from the Supplementary Materials.
The essential oil of chamomile contains mostly oxygenated sesquiterpenes (76.80%), followed by other oxygenated/aromatic compounds (14.45%) and sesquiterpene hydrocarbons (8.71%). Among the identified bioactive compounds, the major ones are bisabolol oxide A (39.49 %), bisabolol oxide B (18.69 %), bisabolone oxide A (12.73 %), ß-farnesene (7.96 %), lachnophyllum ester, trans (6.18 %), and chamazulene (4.24 %) (Figure 2). Based on its chemical profile, the chamomile profile can be classified as chemotype B, also found in Armenia or Albania [4,5,26].
The essential oil of scentless chamomile has a different chemical profile, as revealed by GC-MS analysis. Thus, the major compounds are oxygenated and aromatic compounds (87.98%), with a smaller proportion of sesquiterpene hydrocarbons (11.56%). The predominant bioactive compounds discovered in this essential oil are 1,3-naphthalenediol (69.70 %), followed by lachnophyllum ester, cis (11.59 %), and ß-farnesene (11.56 %) (Figure 2). While β-farnesene and cis-lachnophyllum ester were consistent with previous reports for T. inodorum, the tentative identification of 1,3-naphthalenediol is unexpected due to its low volatility. This signal may instead reflect a possible identification or co-elution with semi-volatile compounds and thus requires cautious interpretation until further validation.
It can be observed that several compounds are present in both species, such as ß-farnesene, lachnophyllum ester, cis, and (Z)-1-[isobenzofuran-1-ylidene]propan-2-one, due to a similar metabolism along the course of evolution, both species belonging to the same taxonomic genus.

3.5. Antioxidant Capacity

The antioxidant activity of the tested extract was evaluated by the DPPH assay, and the IC₅₀ values were calculated using both linear interpolation and nonlinear regression models. For M. chamomilla, based on linear interpolation, the IC₅₀ was estimated at 17.7 µg/mL GAE, whereas the nonlinear 4-parameter logistic (4PL) regression provided a slightly higher value of 21.5 µg/mL GAE (Figure 3). The graphical comparison of the two approaches highlights that the nonlinear model, which accounts for the sigmoidal nature of dose–response relationships, results in a more conservative estimate of IC₅₀ compared to the local linear approximation. These findings indicate that the extract exhibits a moderate free radical scavenging capacity, attributable to its polyphenolic constituents, and confirm the importance of applying appropriate regression models to obtain robust IC₅₀ values.
The IC₅₀ values determined for the extract of T. inodora highlight a moderate antioxidant potential. Using linear interpolation, the IC₅₀ was estimated at 8.40 µg/mL GAE, while nonlinear logistic regression (4PL) provided a slightly higher and more robust estimate of 10.17 µg/mL GAE (95% CI: 7.38–12.96 µg/mL).
The difference between linear and nonlinear estimates underlines the importance of applying regression models that account for the sigmoidal nature of dose–response relationships, particularly when extrapolating IC₅₀ values.

3.6. Antimicrobial Activity

The antimicrobial assays revealed distinct differences between the two chamomile species. The essential oil obtained from T. inodorum exhibited both antibacterial activity against Gram-positive strains and antifungal activity against C. albicans (Figure 4). Antibacterial effects were detected at all tested volumes (5–30 µL), while antifungal inhibition zones were evident at higher volumes (15–30 µL). In contrast, the oil from M. chamomilla displayed only antifungal activity, which was consistently observed across all tested volumes. These findings suggest a broader antimicrobial spectrum for T. inodorum, highlighting its potential as a more effective source of bioactive compounds compared to M. chamomilla.

4. Discussion

The comparative analysis of M. chamomilla and T. inodorum reveals that microscopic, phytochemical, and biological characteristics are closely interconnected, indicating that variations in structural features and chemical composition are reflected in their distinct antioxidant and antimicrobial activities.
This study highlights the diagnostic significance of both morphological and palynological characteristics in distinguishing the two species of chamomile. The observed differences in receptacle structure, ray florets and disc florets are consistent with previously reported taxonomic descriptions and represent reliable characters for species identification [26,27]. These findings underscore the value of detailed floral morphology for accurate species identification, for better knowing the plant material used for medicinal purposes. Palynological characteristics are consistent with previously published studies [26,28,29], and provide reliable diagnostic features for accurate species authentication within the Asteraceae family.
Furthermore, the size, shape, and exine surface of pollen are also important in triggering seasonal allergies. Although allergic reactions to the pollen of these two species are rarely reported, cross-reactive IgE-mediated anaphylactic responses may occur, particularly in individuals sensitized to ragweed or mugwort pollen [30]. Further research is needed to clarify the specific allergenic substances (haptenes), the significance of pollen morphology, and the underlying mechanisms by which these species may induce allergic responses.
Our findings confirm that both M. chamomilla and T. inodorum represent valuable sources of phenolic compounds and flavonoids, yet with distinct chemical signatures. The higher polyphenolic content in M. chamomilla is consistent with recent reports highlighting its well-established antioxidant capacity [3]. Interestingly, the comparatively higher flavonoid levels observed in T. inodorum contrast with previous studies where M. chamomilla was identified as the major flavonoid-rich taxon [2], suggesting possible chemotypic variability or environmental influences on secondary metabolism. This aligns with recent work showing significant fluctuations in phenolic and flavonoid profiles of Asteraceae species depending on harvest season and geographic origin [30].
The IC₅₀ value for M. chamomilla (17.7–21.5 µg/mL) indicates moderate antioxidant activity, consistent with its higher polyphenol content, and falls at the lower end of the wide range reported for chamomile extracts (13.15–73.35 µg/mL), confirming its relevance as a natural source of antioxidants. T. inodorum showed comparable IC₅₀ values (8.4–10.2 µg/mL), which may be attributed to its relatively higher flavonoid content. Although its potency does not approach that of classical antioxidants such as ascorbic acid or quercetin (IC₅₀ < 5 µg/mL), its activity is consistent with other medicinal plants of moderate radical-scavenging capacity. These findings underline the importance of considering both phenolic and flavonoid fractions when evaluating antioxidant potential, which is why the antioxidant capacity was assessed on hydroethanolic extracts, where such compounds are the main contributors to radical scavenging activity. In contrast, antimicrobial assays were performed on essential oils, rich in volatile terpenoids with well-documented antibacterial and antifungal effects. This complementary approach allowed us to capture the distinct bioactive potential of the polar versus volatile fractions of the two chamomile species.
Regarding the chemical composition of the two essential oils, the diversity of the identified bioactive compounds is notable, offering multiple possible therapeutical applications. Chemical profile of M. chamomilla essential oil, with bisabolol oxide A as the major compound (39.49 %) placed this Romanian species in the chemotype B, as previously described by literature [26]. Bisabolol oxides (A and B), as natural derivates of α- bisabolol, by oxidation, are known for their anti-inflammatory, antimicrobial, and wound-healing properties [31]. Tomić et al highlighted the antihyperalgesic, anti-inflammatory, and antiedematous effects of a bisabolol-oxides-rich Matricaria essential oil in a rat model of inflammation induced by carrageenan, dextran, and histamine [32]. In another study, Alimi et al, revealed that bisabolol oxide A showed good activity against Staphylococcus aureus, Escherichia coli, and Salmonella enteritidis, ovicidal and larvicidal against Hyalomma scupense, and potent anti-acetylcholinesterase activity [33]. A randomized controlled trial on 29 patients with chronic venous leg ulcers showed that a spray formulation containing ozonated oil and α-bisabolol used in topical treatment was significantly efficient in reducing the wound size and increasing the rate of complete ulcer closure [34]. Two other major compounds, bisabolol oxide B (18.69%), and bisabolone oxide A (12.73 %), with biological activities comparable to bisabolol oxide A, further enhance the overall bioactivity of chamomile essential oil. β-Farnesene, beyond its antimicrobial and anti-inflammatory potential, functions as an ecological signaling compound, acting as an alarm pheromone in certain insects and as a plant defense metabolite against herbivory [35,36]. Lachnophyllum ester, known for its antifungal activity against dermatophytes such as Trichophyton rubrum and Microsporum canis [37], as well as for its significant antioxidant capacity, adds an important contribution to the bioactive profile of the essential oil. An important compound, found in the essential oil of chamomile, that gives its blue color, is chamazulene, a sesquiterpene derivate. In the Romanian analyzed sample, the chamazulene content (4.24%) falls within the range reported in the literature (2.3–10.9%) [26]. Chamazulene is generated from matricin, during hydrodistillation, and has notable anti-inflammatory, antispasmodic, and antioxidant properties, thereby contributing significantly to the species pharmacological profile, along with the other compounds [6,38].
In contrast, the essential oil of T. inodorum displays a comparatively simpler phytochemical profile, characterized by fewer bioactive constituents. Lachnophyllum ester, cis, a polyunsaturated fatty ester, as a major compound (11.59 %), provides significant contributions to the bioactive profile of the essential oil, through its antifungal and antioxidant activities. Interestingly, recent studies showed that lachnophyllum ester exhibit cytotoxic activity against MDA-MD-231, MCF-7, 5637 human tumor cells, and SK-MEL-28 melanoma cells, by increasing ROS production, which makes our plants candidates for anticancer therapy [39,40]. β-Farnesene, a sesquiterpene alkene accounting for 11.56% of the composition, is also known to function as a component of the aphid alarm pheromone. Apart from its ecological role, β-farnesene demonstrates biological properties such as anti-inflammatory and neuroprotective activities. Turkez et al noticed it has a dose-related neuroprotective action on cultured rat primary cortical neurons, reducing DNA damage, thus suggesting possible applications in neurodegenerative and oxidative stress related disorders [41]. These diverse biological actions of the bioactive compounds from the two chamomile species suggest interest for both ecological agricultural applications, and for developing new therapeutic agents for human health.
The chemical composition differences of the essential oils are reflected in their biological activity, as shown by our results.
The broader antimicrobial spectrum of T. inodora essential oil, active against both S. aureus and C. albicans, contrasts with the strictly antifungal effect of M. chamomilla. This difference reflects their distinct chemotypes, with β-farnesene and lachnophyllum ester in T. inodora linked to antimicrobial activity, while bisabolol derivatives in M. chamomilla are primarily associated with anti-inflammatory and antifungal effects. Our findings are consistent with previous reports: M. chamomilla oils are known to inhibit Candida species, particularly due to α-bisabolol oxides and chamazulene, whereas T. disciforme [421] and T. inodorum extracts [43,44] demonstrated antibacterial and antifungal activity. Together, these results confirm that both volatile and polar fractions of T. inodorum contribute to its antimicrobial potential, supporting its recognition as an underexplored source of bioactive metabolites.
Future research is needed to deepen the understanding of the chemical profiles of both chamomile species, identifying potential new pharmacological effects, and evaluate their safety and toxicity.

5. Conclusions

This study provides an integrative characterization of Matricaria chamomilla and Tripleurospermum inodorum, revealing distinct morphological, chemical, and biological features. M. chamomilla exhibited higher total polyphenols and an essential oil dominated by oxygenated sesquiterpenes such as bisabolol oxides and chamazulene, whereas T. inodorum contained more flavonoids and an essential oil rich in β-farnesene and cis-lachnophyllum ester. Both species showed moderate antioxidant capacity, while T. inodorum demonstrated broader antimicrobial activity, being active against both Staphylococcus aureus and Candida albicans. These results emphasize the chemical distinctiveness and bioactive potential of T. inodorum, supporting its consideration as a complementary natural source of antioxidant and antimicrobial compounds.

Supplementary Materials

The following supporting information can be downloaded at the website of this paper posted on Preprints.org, Figure S1: Disc florets in microscopic view (10×); Figure S2: Pollen grains in microscopic view (100×); Figure S3: GC-MS chromatogram of M. chamomilla.; Figure S4: GC-MS chromatogram of T. inodorum.

Author Contributions

Conceptualization, M.P. and M.L.G.; methodology, M.P., M.L.G.,.; software, R.C.S..; validation, C.E.M.., R.C.S..; formal analysis, M.P. and M.L.G.; investigation, M.P., M.L.G.; M.P., and E.P; resources, M.P., E.P., and M.L.G.;.; data curation, R.C.S, and C.E.M.; writing—original draft preparation, M.P. and M.L.G..; writing—review and editing, M.P., M.L.G. and E.P..; visualization, M.P..; supervision, R.C.S.. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Haţieganu, E.; Gălăţanu, M.L. Botanică farmaceutică. Sistematică vegetală. Editura Hamangiu, Bucureşti, Romania, 2023; pp 301 - 302.
  2. Sheydaei, P.; Duarte, A.P. The Genus Tripleurospermum Sch. Bip. (Asteraceae): A Comprehensive Review of Its Ethnobotanical Utilizations, Pharmacology, Phytochemistry, and Toxicity. Life 2023, 13, 1323. [CrossRef]
  3. El Mihyaoui, A.; Esteves da Silva, J.C.G.; Charfi, S.; Candela Castillo, M.E.; Lamarti, A.; Arnao, M.B. Chamomile (Matricaria chamomilla L.): A Review of Ethnomedicinal Use, Phytochemistry and Pharmacological Uses. Life 2022, 12, 479. [CrossRef]
  4. Orav, A.; Raal, A.; Arak, E. Content and composition of the essential oil ofChamomilla recutita(L.) Rauschert from some European countries. Nat. Prod. Res. 2010, 24, 48–55. [CrossRef]
  5. Salamon, I.; Ibraliu, A.; Kryvtsova, M. Essential Oil Content and Composition of the Chamomile Inflorescences (Matricaria recutita L.) Belonging to Central Albania. Horticulturae 2023, 9, 47. [CrossRef]
  6. Srivastava, J. K.; Shankar, E.; Gupta, S. Chamomile: A herbal medicine of the past with bright future. Mol. Med. Rep., 2010, 3, 895–901.
  7. Wichtl, M. Herbal Drugs and Phytopharmaceuticals: A Handbook for Practice on a Scientific Basis, 3rd ed.; MedPharm Scientific Publishers: Stuttgart, Germany, 2004; pp. 322–325.
  8. Amsterdam, J.D.; Li, Y.; Soeller, I.M.; Rockwell, K.; Mao, J.J.; Shults, J. A Randomized, Double-Blind, Placebo-Controlled Trial of Oral Matricaria recutita (Chamomile) Extract Therapy for Generalized Anxiety Disorder. J. Clin. Psychopharmacol. 2009, 29, 378–382. [CrossRef]
  9. Amsterdam, J.D.; Shults, J.; Soeller, I.; Mao, J.J.; Rockwell, K.; Newberg, A.B. Chamomile (Matricaria recutita) May Provide Antidepressant Activity in Anxious, Depressed Humans: An Exploratory Study. 2012, 18, 44–49.
  10. Zhao, Y.; Wang, C.; Goel, R.; Rojo de la Vega, M.; Zhang, D. D. Effects of chamomile on sleep quality: A systematic review and meta-analysis. Phytother. Res., 2019, 33, 482–491.
  11. Bakhsha, F.; Bahrami, N.; Eghbali-Babadi, M.; Hamidizadeh, S. The effect of chamomile oil on pain and function in patients with mild to moderate carpal tunnel syndrome: A randomized controlled trial. Complement. Ther. Clin. Pract., 2021, 42, 101284.
  12. Segal, R.; Pilote, L. Warfarin interaction with Matricaria chamomilla. Can. Med Assoc. J. 2006, 174, 1281–1282. [CrossRef]
  13. Ivanova, D.; Todorova, M.; Stoyanova, A. Comparative morphological and chemical study of Tripleurospermum inodorum and Matricaria chamomilla. J. Pharm. Sci. Res., 2018, 10, 771–775.
  14. Gülçin, İ.; Kırkan, B.; Beydemir, Ş. Antioxidant and antimicrobial activities of Tripleurospermum inodorum extracts. J. Med. Plants Res., 2022, 16, 45–52.
  15. Suleimen, Y.М.; Van Hecke, K.; Ibatayev, Z.A.; Iskakova, Z.B.; Akatan, K.; Martins, C.H.G.; Silva, T.S. Crystal Structure and Biological Activity of Matricaria Ester Isolated from Tripleurospermum Inodorum (L.) Sch. Bip.. J. Struct. Chem. 2018, 59, 988–991. [CrossRef]
  16. Mahernia, S.; Bagherzadeh, K.; Mojab, F.; Amanlou, M. Urease Inhibitory Activities of some Commonly Consumed Herbal Medicines. 2015, 14, 943–947.
  17. Punt, W.; Hoen, P.P.; Blackmore, S.; Nilsson, S.; Le Thomas, A. Glossary of pollen and spore terminology. Rev. Palaeobot. Palynol. 2007, 143, 1–81. [CrossRef]
  18. Erdtman, G. The acetolysis method: A revised description. Svensk Bot. Tidskr. 1960, 54, 561–564.
  19. Rîmbu, M.C.; Cord, D.; Savin, M.; Grigoroiu, A.; Mihăilă, M.A.; Gălățanu, M.L.; Ordeanu, V.; Panțuroiu, M.; Țucureanu, V.; Mihalache, I.; et al. Harnessing Plant-Based Nanoparticles for Targeted Therapy: A Green Approach to Cancer and Bacterial Infections. Int. J. Mol. Sci. 2025, 26, 7022. [CrossRef]
  20. Gălățanu, M.L.; Panțuroiu, M.; Cima, L.M.; Neculai, A.M.; Pănuș, E.; Bleotu, C.; Enescu, C.M.; Mircioiu, I.; Gavriloaia, R.M.; Aurică, S.N.; Rîmbu, M.C.; Sandulovici, R.C. Title of the Article. Molecules 2025, 30, 913.
  21. Farmacopeea Română, Xth ed.; Editura Medicală: București, Romania, 1993; pp. 335.
  22. European Pharmacopoeia, 12th ed.; European Directorate for the Quality of Medicines & HealthCare (EDQM): Strasbourg, France, 2025.
  23. Panturoiu, M.; Galatanu, M.L.; Cristache, R.E.; Truta, E. Characterisation of nutraceutical fatty acids and amino acids in the buds of Populus nigra, Populus alba, and Populus × euramericana by gas chromatography. J. Sci. Arts 2025, 25, 395.
  24. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing, 33rd ed.; CLSI document M100; CLSI: Wayne, PA, USA, 2023.
  25. Clinical and Laboratory Standards Institute (CLSI). Development of In Vitro Susceptibility Test Methods, Breakpoints, and Quality Control Parameters, 6th ed.; CLSI document M23; CLSI: Wayne, PA, USA, 2023.
  26. Singh, O.; Khanam, Z.; Misra, N.; Srivastava, M.K. Chamomile (Matricaria chamomilla L.): An overview. Pharmacogn. Rev. 2011, 5, 82–95. [CrossRef]
  27. Wilcox, M. Examining Tripleurospermum inodorum (Scentless False Mayweed). Br. Ir. Bot. 2022, 4(2), 113–146. [CrossRef]
  28. Khan, S.; Jan, G.; Ahmad, M.; Gul, F.; Zafar, M.; Mangi, J.U.D.; Bibi, H.; Sultana, S.; Usma, A.; Majeed, S. Morpho-palynological assessment of some species of family Asteraceae and Lamiaceae of District Bannu, Pakistan on the bases of light microscope & scanning electron microscopy. Microsc. Res. Tech. 2021, 84, 1220–1232. [CrossRef]
  29. Tümen, G.; Öztürk, M. The comparative pollen morphology of genera Matricaria L. and Tripleurospermum Sch. Bip. (Asteraceae) in Turkey. Turk. J. Bot. 2012, 36, 1–10. [CrossRef]
  30. Ključevšek, T.; Kreft, S. Allergic Potential of Medicinal Plants From the Asteraceae Family. Heal. Sci. Rep. 2025, 8, e70398. [CrossRef]
  31. Akram, W.; Ahmed, S.; Rihan, M.; Arora, S.; Khalid, M.; Ahmad, S.; Ahmad, F.; Haque, S.; Vashishth, R. An updated comprehensive review of the therapeutic properties of Chamomile ( Matricaria chamomilla L.). Int. J. Food Prop. 2023, 27, 133–164. [CrossRef]
  32. Tomić, M.; Popović, V.; Petrović, S.; Stepanović-Petrović, R.; Micov, A.; Pavlović-Drobac, M.; Couladis, M. Antihyperalgesic and Antiedematous Activities of Bisabolol-Oxides-Rich Matricaria Oil in a Rat Model of Inflammation. Phytotherapy Res. 2013, 28, 759–766. [CrossRef]
  33. Alimi, D.; Hraoui, M.; Hajri, A.; Taamalli, W.; Selmi, S.; Sebai, H. Bioactivity and molecular docking studies of selected plant compounds. J. Sci. Food Agric. 2024, 104, 4391–4399. [CrossRef]
  34. Solovăstru, L.G.; Stîncanu, A.; De Ascentii, A.; Capparé, G.; Mattana, P.; Vâţă, D. Randomized, Controlled Study of Innovative Spray Formulation Containing Ozonated Oil and α-Bisabolol in the Topical Treatment of Chronic Venous Leg Ulcers. Adv. Ski. Wound Care 2015, 28, 406–409. [CrossRef]
  35. Nayak, B.; Pelly, S.; Hagele, G.; Cote, G.; et al. Neutrophil immunomodulatory activity of farnesene, a component of Artemisia dracunculus essential oils. Molecules 2022, 27, 4871.
  36. Wang, B.; Dong, W.; Li, H.; D’onofrio, C.; Bai, P.; Chen, R.; Yang, L.; Wu, J.; Wang, X.; Wang, B.; et al. Molecular basis of (E)-β-farnesene-mediated aphid location in the predator Eupeodes corollae. Curr. Biol. 2022, 32, 951–962.e7. [CrossRef]
  37. Sobrinho, A.C.N.; Fontenelle, R.O.S.; Souza, E.B.; Morais, S.M. Antifungal and antioxidant effect of the lachnophyllum ester, isolated from the essential oil of Baccharis trinervis (Lam.) Pers., against dermatophytes fungi. Rev. Bras. Saude Prod. Anim. 2021, 22, e2122542021. [CrossRef]
  38. McKay, D.L.; Blumberg, J.B. A Review of the bioactivity and potential health benefits of chamomile tea (Matricaria recutita L.). Phytother. Res. 2006, 20, 519–530. [CrossRef]
  39. Satyal, P.; Chhetri, B.K.; Dosoky, N.S.; Shrestha, S.; Poudel, A.; Setzer, W.N. Chemical Composition of Blumea lacera Essential Oil from Nepal. Biological Activities of the Essential Oil and (Z)-Lachnophyllum Ester. Nat. Prod. Commun. 2015, 10, 1749–50. [CrossRef]
  40. Ferreira, R.C.; Nascimento, Y.M.D.; Loureiro, P.B.d.A.; Martins, R.X.; Maia, M.E.d.S.; Farias, D.F.; Tavares, J.F.; Gonçalves, J.C.R.; da Silva, M.S.; Sobral, M.V. Chemical Composition, In Vitro Antitumor Effect, and Toxicity in Zebrafish of the Essential Oil from Conyza bonariensis (L.) Cronquist (Asteraceae). Biomolecules 2023, 13, 1439. [CrossRef]
  41. Turkez, H.; Sozio, P.; Geyikoglu, F.; Tatar, A.; Hacimuftuoglu, A.; Di Stefano, A. Neuroprotective Effects of Farnesene Against Hydrogen Peroxide-Induced Neurotoxicity In vitro. Cell. Mol. Neurobiol. 2013, 34, 101–111. [CrossRef]
  42. Chehregani, A.; Mohsenzadeh, F.; Mirazi, N.; Hajisadeghian, S.; Baghali, Z. Chemical composition and antibacterial activity of essential oils ofTripleurospermum disciformein three developmental stages. Pharm. Biol. 2010, 48, 1280–1284. [CrossRef]
  43. Marakhova, A.; Zhilkina, V.Y.; Elapov, A.; Sachivkina, N.; Samorodov, A.; Pupykina, K.; Krylova, I.; Kezimana, P.; Stoynova, A.M.; Venkatesan, R.; et al. The Development of a Method for Obtaining Tripleurospermum inodorum (L.) Sch. Bip. Herb Extract Enriched with Flavonoids and an Evaluation of Its Biological Activity. Plants 2024, 13, 1629. [CrossRef]
  44. Ivanov, M.; Aleksandrov, A.P.; Božunović, J.; Dias, M.I.; Calhelha, R.C.; Kulaš, J.; Barros, L.; Ferreira, I.C.F.R.; Stojković, D. Bioactive potential of Tripleurospermum inodorum with detailed insight into anti-inflammatory activity through in vitro, in vivo evaluations and network pharmacology. Inflammopharmacology 2025, 33, 3363–3376. [CrossRef]
Figure 1. Flowers capitulum of chamomile species. (a) M. chamomilla; (b) T. inodorum.
Figure 1. Flowers capitulum of chamomile species. (a) M. chamomilla; (b) T. inodorum.
Preprints 179887 g001
Figure 2. Bioactive compounds from the two chamomile essential oils. (a) bisabolol oxide A; (b) bisabolol oxide B; (c) bisabolone oxide A; (d) α-bisabolol; (e) ß-farnesene; (f) lachnophyllum ester, cis.
Figure 2. Bioactive compounds from the two chamomile essential oils. (a) bisabolol oxide A; (b) bisabolol oxide B; (c) bisabolone oxide A; (d) α-bisabolol; (e) ß-farnesene; (f) lachnophyllum ester, cis.
Preprints 179887 g002
Figure 3. IC₅₀ determination by linear and nonlinear regression (DPPH assay). (a) M. chamomilla; (b) T. inodorum.
Figure 3. IC₅₀ determination by linear and nonlinear regression (DPPH assay). (a) M. chamomilla; (b) T. inodorum.
Preprints 179887 g003
Figure 4. Inhibition zones (mm) produced by essential oils of M. chamomilla and T. inodorum against Staphylococcus aureus ATCC 25923 and Candida albicans ATCC 10231. (a) M. chamomilla; (b) T. inodorum.
Figure 4. Inhibition zones (mm) produced by essential oils of M. chamomilla and T. inodorum against Staphylococcus aureus ATCC 25923 and Candida albicans ATCC 10231. (a) M. chamomilla; (b) T. inodorum.
Preprints 179887 g004
Table 1. Morphological characteristics of M. chamomilla and T. inodorum.
Table 1. Morphological characteristics of M. chamomilla and T. inodorum.
No. Feature M. chamomilla T. inodorum
1. Receptacle Conical, hollow Flat, solid
2. Ray florets Female (fertile); ~6–12 mm long, ~2–3 mm wide; white; 3-dentate apex Female or sterile; ~8–20 mm long, ~3–4 mm wide; white; 3-lobed apex
3. Disc florets Bisexual (fertile), tubular, 5-lobed; ~1.2–2.5 mm long, bright yellow, densely packed on receptacle Bisexual (fertile), tubular,
5-lobed; ~1–2.5 mm long,
yellow- golden, less compact arrangement
4. Pollen grain Spheroidal, tricolporate, isopolar, echinate (spiny), ~22–27 µm diameter; well-
developed ornamentation
Spheroidal, tricolporate, echinate, slightly larger (~25–30 µm); less pronounced
ornamentation
Table 2. Total polyphenol content in the two chamomile species.
Table 2. Total polyphenol content in the two chamomile species.
Plant material Total polyphenols
(mg GAE/g DW)
Total polyphenols
(mg CAE/g DW)
M. chamomilla 20.48 ± 0.004 20.10 ± 0.005
T. inodorum 17.88 ± 0.007 17.73 ± 0.008
Table 3. Total flavonoid content in the two chamomile species.
Table 3. Total flavonoid content in the two chamomile species.
Plant material Total Flavonoid Content
(mg RE/g DW)
M. chamomillae 13.872 ± 0.009
T. inodorum 15.925 ± 0.005
Table 4. GC/MS analysis of Matricaria chamomilla essential oil.
Table 4. GC/MS analysis of Matricaria chamomilla essential oil.
No. Compound Retention Time
(min)
Area Height Relative Area %
1 ß-Farnesene 30.577 11169657.386 116905470.279 7.96
2 Germacrene 32.831 62595274.131 17918063.213 0.75
3 Spatulenol 37.415 17918903.014 3301322.462 0.72
4 Spatulenal 38.402 30916297.237 8638674.702 1.24
5 α-Bisabolol oxide B 42.191 471485715.521 148554907.712 18.69
6 α-Bisabolone oxide A 43.093 18983527.674 181136140.411 12.73
7 (Z)-1-[Isobenzofuran-1-ylidene]propan-2-one 43.429 1568719.564 24697369.809 2.39
8 α-Bisabolol 44.239 1357533.047 21521213.089 3.93
9 Lachnophyllum ester, cis 44.436 2190279.545 42077995.355 1.64
10 Lachnophyllum ester, trans 46.280 8708918.619 173380009.967 6.18
11 Chamazulene 47.749 5743564.753 94479030.964 4.24
12 α-Bisabolol oxide A 48.354 51901624.258 771403692.014 39.49
Total:684,540,014.749 1,604,013,889.977 99.96
Table 5. GC/MS analysis of Matricaria inodora essential oil.
Table 5. GC/MS analysis of Matricaria inodora essential oil.
No. Compound Retention Time
(min)
Area Height Relative Area %
1 ß-Farnesene 30.566 34590686.315 366577084.465 11.56
2 (Z)-1-[Isobenzofuran-1-ylidene]propan-2-one 43.422 10909360.278 216847108.997 3.58
3 Lachnophyllum ester, cis 44.433 34353158.511 732516145.799 11.59
4 Naphthalenone 44.858 4057443.103 83895606.846 1.53
5 Isobenzofuran 45.116 1838183.291 35163758.832 0.67
6 1,3-Naphthalenediol 46.307 212146525.675 4076885682.106 69.70
7 6,7-Dimethyl-1-
naphthol
48.844 24288.275 615485.818 0.91
Total:297919645.449 5512500872.863 99.54
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings

© 2025 MDPI (Basel, Switzerland) unless otherwise stated